KindVR’s mission is to help patients mitigate pain and stress by developing virtual reality therapies for specific medical procedures and conditions.
We are a research-based company, partnering with leading US and Canadian hospitals. Our goal is to make it easy for hospitals to provide virtual reality therapy to every patient in need.
Today, KindVR has eight clinical trials underway with leading research hospitals across the US and Canada. KindVR therapy is being tested with patients experiencing mediport access procedures, MRI procedures, emergency room visits, and pre-operative stress.
Beyond the research, many hospitals are beginning to use KindVR therapy routinely with their patients.
KindVR was founded in 2014 by Simon Robertson, a game developer and Child Life Volunteer at UCSF Benioff Children’s Hospital Oakland. When he discovered no hospitals were using virtual reality despite 20 years of clinical research on VR's efficacy, he created KindVR to make it easy to provide VR therapy to patients in need.
His key insight was that each VR experience should be developed for a specific hospital procedure or medical condition. Today, all of KindVR's experiences are clinically validated to demonstrate that they are safe and effective. All of KindVR's therapies are developed in-house by the KindVR development team.
Helping to Educate about Virtual Reality Therapy
In addition to research and supporting hospital programs, KindVR participates in many medical conferences, presenting research findings and conducting demonstrations of VR therapy.
American Academy of Pediatrics
KindVR provides hundreds of demonstrations of VR therapy at medical conferences across the US. (Photo from AAP2016)
The Associaction of Child Life Professionals
KindVR supports Child Life Specialists and participates in the annual ACLP Conference. Child Life Specialists participating in our trials share our research results at regional CL conferences.
The Royal College of Physicians in London
We were invited to share our results from our first Sickle Cell VR trial at the Academy for Sickle Cell and Thalassaemia Conference at the Royal College of Physicians in London in 2016.